Design, synthesis, and target identification of new hypoxia-inducible factor 1 (HIF-1) inhibitors containing 1-alkyl-1H-pyrazole-3-carboxamide moiety
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 46, 116375
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology (17H06401, 19H02840)
This publication has 22 references indexed in Scilit:
- Design, synthesis, and structure–activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitorsBioorganic & Medicinal Chemistry, 2015
- UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1αNature Communications, 2015
- A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitorsNature Chemical Biology, 2014
- Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vesselsNature Communications, 2012
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsOncogene, 2009
- Modulating Hypoxia-Inducible Transcription by Disrupting the HIF-1–DNA InterfaceACS Chemical Biology, 2007
- (Aryloxyacetylamino)benzoic Acid Analogues: A New Class of Hypoxia-Inducible Factor-1 InhibitorsJournal of Medicinal Chemistry, 2007
- Oligomycin inhibits HIF-1α expression in hypoxic tumor cellsAmerican Journal of Physiology-Cell Physiology, 2005
- A Simple Polyheterotopic Molecular Receptor Derived from Bispyrazolylmethane Showing Ambivalent Allosteric Cooperation of Zinc(II)European Journal of Organic Chemistry, 2000
- Utilization of operational schemes for analog synthesis in drug designJournal of Medicinal Chemistry, 1972